TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,646,000 | +128.4% | 48,452 | -18.5% | 0.99% | +138.9% |
Q1 2022 | $1,596,000 | -28.0% | 59,452 | +28.0% | 0.42% | -25.3% |
Q4 2021 | $2,216,000 | -20.5% | 46,452 | +10.7% | 0.56% | -24.6% |
Q3 2021 | $2,787,000 | -25.3% | 41,952 | -12.3% | 0.74% | -5.4% |
Q2 2021 | $3,733,000 | +275.6% | 47,852 | +355.3% | 0.78% | +230.9% |
Q1 2021 | $994,000 | -33.7% | 10,509 | -54.7% | 0.24% | -45.5% |
Q2 2020 | $1,499,000 | -28.4% | 23,210 | -50.5% | 0.43% | -50.5% |
Q1 2020 | $2,095,000 | +10.6% | 46,908 | +54.3% | 0.87% | +34.5% |
Q4 2019 | $1,894,000 | +6.5% | 30,408 | -35.7% | 0.65% | -2.8% |
Q3 2019 | $1,779,000 | – | 47,308 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |